Eric Lowe at NIH

Eric Lowe has been selected as a patient participant to NIH’s State of the Science Workshop of FVIII Immunogenicity - Prospective Database and Biospecimen Collection Infrastructure Working Group. The working groups will share their findings at the National Heart Lung Blood Institute State of the Science Workshop on May 15-16, 2018 at the NIH campus in Washington, DC.

The goal of the workshop is to solicit input from all constituencies within the US hemophilia community, as well as international collaborators, into the development of a coordinated and collaborative national blueprint for future basic, translational, and clinical research focused on factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention and eradication.